{{Rsnum
|rsid=6599077
|Gene=MYRIP
|Chromosome=3
|position=40055127
|Orientation=plus
|GMAF=0.3136
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MYRIP
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 9.2 | 32.3 | 58.5
| HCB | 18.6 | 41.9 | 39.5
| JPT | 11.6 | 41.9 | 46.5
| YRI | 6.3 | 60.3 | 33.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 18.6 | 41.9 | 39.5
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs6599077
|PubMedID=17903308
|Condition=Sleep duration
|Gene=MYRIP
|Risk Allele=
|pValue=1.00E-007
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs6599077
|Name_s=
|Gene_s=MYRIP
|Feature=
|Evidence=PubMed ID:17903308; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association of sleep and circadian phenotypes (Initial Sample Size: 738 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Sleep duration.
|Drugs=
|Drug Classes=
|Diseases=Sleep Disorders
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356472
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6599077
|overall_frequency_n=31
|overall_frequency_d=128
|overall_frequency=0.242188
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=30
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}